Depending on the context of the infection or pathology, a blocking antibody, for example, directed against CD200R to block its interaction with CD200, could be effective in counteracting infections by pathogens whose survival is favored by, or associated with, overexpression of CD200R, complemented by conventional antimicrobial treatment. Here, CD200R1 is linked to infection.